Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Other Non-Current Liabilities (2024 - 2025)

Historic Other Non-Current Liabilities for Krystal Biotech (KRYS) over the last 2 years, with Q4 2025 value amounting to $3.7 million.

  • Krystal Biotech's Other Non-Current Liabilities rose 16243.83% to $3.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.7 million, marking a year-over-year increase of 16243.83%. This contributed to the annual value of $3.7 million for FY2025, which is 16243.83% up from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Other Non-Current Liabilities is $3.7 million, which was up 16243.83% from $3.1 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Other Non-Current Liabilities registered a high of $3.7 million during Q4 2025, and its lowest value of $588000.0 during Q2 2024.